Randomized, double-blind trial comparing indinavir alone, zidovudine alone and indinavir plus zidovudine in antiretroviral therapy-naive hiv-infected individuals with CD4 cell counts between 50 and 250/mm3

Treatment with indinavir has been shown to result in marked decreases in viral load and increases in CD4 cell counts in HIV-infected individuals. A randomized double-blind study to evaluate the efficacy of indinavir alone (800 mg q8h), zidovidine alone (200 mg q8h) or the combination was performed t...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	David S. LEWI, Jamal M. SULEIMAN, David E. UIP, Rogerio J. PEDRO, Rosa A. SOUZA, Grace S. SULEIMAN, Conceição ACCETTURI, Olavo M. LEITE, William B. ABREU, Artur O. KALICHMAN, Joaquim P.P. MORAES-FILHO, Eduardo F. MOTTI, Maria Lucia C. PECORARO, Mark R. MAKURATH, Michael L. NESSLY, Randi Y. LEAVITT
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Universidade de São Paulo (USP) 2000-02-01
סדרה:	Revista do Instituto de Medicina Tropical de São Paulo
נושאים:	Randomized study Double blind clinical trial HIV AIDS Protease inhibitors Indinavir Zidovudine Disease progression Therapy Clinical endpoint
גישה מקוונת:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0036-46652000000100005&tlng=en
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!